Daniel DeNeui is an accomplished entrepreneur and executive widely recognized for his expertise in strategic planning, business development, and executive coaching. With a deep understanding of human behavior and psychology complemented by his skill in public speaking, he has founded and grown multiple multi-million dollar businesses, each from minimal startup investments.

As the CEO of EVEXIAS Health Solutions®, Daniel leads an innovative organization dedicated to transforming medical wellness. His strategic leadership focuses on reinvigorating healthcare practitioners' passions and enhancing patient care through cutting-edge approaches.

Collaborating with his spouse, he oversees the strategic vision of the EVEXIAS-FarmaKeio organization, aiming to revolutionize healthcare by broadening the reach of life-changing educational and therapeutic solutions. Since taking on the CEO role in 2015, his broad expertise in science and business has driven expanding and enhancing the company’s services, including pioneering the EvexiPEL® Method, PeptideSolutions™, and NutraceuticalSolutions™.

At EVEXIAS, Daniel is committed to developing personalized wellness plans that integrate a functional and holistic approach to medicine. These plans target the root causes of health conditions, explicitly addressing symptoms of hormone imbalance with innovative treatments such as bioidentical hormone replacement therapy and advanced nutraceuticals, ensuring they are tailored to individual patient needs.

Under Daniel's guidance, EVEXIAS has embraced technological innovations to improve healthcare delivery and education. In 2022, he initiated EVEXIAS Online, a platform to foster collaboration and continuous learning among healthcare professionals. This platform allows practitioners to share insights, discuss complex cases, and access extensive educational resources. Furthermore, in early 2023, he spearheaded the most comprehensive training program in the organization’s history to enhance practical skills in hormone therapy.

Before his current role, Daniel held key executive positions at Asperio Labs and BioTE Medical, where he focused on hormone optimization and promoting strategies for healthy aging. His earlier roles at Independent Producers of America and Cornerstone America were instrumental in developing national sales strategies and expanding business operations.

Daniel DeNeui’s educational background in organic chemistry from Clemson University has been foundational in his career, providing a strong scientific basis for his business and healthcare innovations. Beyond his professional life, he is dedicated to philanthropy, supporting charities that help families navigate unexpected life challenges.